Quick answers
- What is Sulfameth/Trimeth-DS?
- Sulfameth/Trimeth-DS is a brand name of Sulfamethoxazole and trimethoprim, a prescription medicine. The FDA NDC Directory lists 1 Sulfameth/Trimeth-DS product in 1 strength and form.
- Who makes Sulfameth/Trimeth-DS?
- Aurobindo Pharma holds the FDA application for Sulfameth/Trimeth-DS (ANDA090624, approved February 16, 2010).
- Is there a generic or store brand of Sulfameth/Trimeth-DS?
- Yes. The FDA NDC Directory lists 67 other products with the same active ingredients, strength and form as a Sulfameth/Trimeth-DS product, 66 of them generic. Ask your pharmacist whether one is right for you.
- Has Sulfameth/Trimeth-DS been recalled?
- No recall linked to Sulfameth/Trimeth-DS products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Sulfameth/Trimeth-DS is
Each Sulfameth/Trimeth-DS product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Sulfamethoxazole and trimethoprim · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| sulfamethoxazole 800 mg · trimethoprim 160 mg tablet (oral) | Sulfameth/Trimeth-DS | 67 products, 35 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Sulfamethoxazole and trimethoprim →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA090624 | Aurobindo Pharma | February 16, 2010 | 1 |
Companies that list Sulfameth/Trimeth-DS
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Sulfameth/Trimeth-DS products.
- Direct_Rx1 product
Recalls
No recall linked to Sulfameth/Trimeth-DS products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.